Belinda B. Willard, PhD
Co-Director, Proteomics Core Facilitywillarb@ccf.org 216.444.7170 (o)
Staff, Cell Biology
Member, Nonprogrammatically Aligned
Belinda B. Willard, PhD, has been the Proteomics and Metabolomics Core Director for the Cleveland Clinic Lerner Institute since 2014. Before that, she was the Proteomics Core Director from 2008 to 2014 and a postdoctoral fellow from 2000 to 2008. She was a research assistant at Carnegie Mellon University from 1997 to 1999 and a teaching assistant from 1994 to 1996. In 1993, she was in the NSF-REU Program at the University of Kentucky. Dr. Willard earned her BS in chemistry from Mount Union College in 1994. She earned her PhD in chemistry from Carnegie Mellon University in 2000. She was a postdoctoral fellow in proteomics at the Cleveland Clinic until 2008.
Dr. Willard’s expertise is in the use of mass spectrometry-based proteomics in the study of biological systems. She has contributed to numerous studies on the identification of post-translational modification through the identification of modifications on specific proteins. Dr. Willard has also been involved in the design and analysis of experiments related to the identification of global phosphorylation,acetylation, nitrosylation, and the analysis of lipid oxidized peptides.
Dr. Willard has twenty years experience working with using mass spectrometry as an analytical tool, starting with her use of mass spectrometry to understand how organo-silicon ions fragment in the gas phase. Her initial work in the Proteomics Core involved trying to better understand how peptides fragment in a mass spectrometer.
mass spectrometry, biological systems, post-translational modification, proteins, global phosphorylation, acetylation, nitrosylation, lipid oxidized peptides